November 24, 2020
University of Cincinnati researchers have discovered new clues into why some people with head and neck cancer respond to immunotherapy, while others don’t.
August 27, 2021
The school year rapidly approaches amid a surge in pediatric COVID-19 hospitalizations, and parents desperately want to know: When can young children get the vaccine? UC's Carl Fichtenbaum weighs in.
August 26, 2021
Researchers at the University of Cincinnati and UC Health have administered a first-of-its-kind potential COVID-19 therapy. The first dosing was administered to a patient at UC Medical Center in Cincinnati on Aug. 17.
September 28, 2021
The University of Cincinnati College of Medicine is opening what it calls a “heart bank” to collect tissue samples that can be used by researchers. Those samples will be stored in a biorepository to provide a potentially valuable resource to help researchers find answers to scientific questions.
November 17, 2022
According to a report in early 2022 from the Centers for Disease Control and Prevention, more than 37 million people in the United States have diabetes, which is more than 11% of the population. Diabetes was the seventh leading cause of death in the United States in 2017 based on the death certificates in which diabetes was listed as the underlying cause of death. A newly launched University of Cincinnati partnership is aiming to put a dent in those numbers in Greater Cincinnati.
February 22, 2021
Shaina Horner, a clinical researcher in the Division of Infectious Diseases used her connections in the local Latinx community to help recruit a diverse population for the Moderna COVID-19 vaccine trial.
May 13, 2021
Donald Lynch Jr., MD, assistant professor at the University of Cincinnati College of Medicine, will be presenting preliminary research at the American College of Cardiology on Saturday, May 15, that suggests plasma proteins discovered in the blood samples of diabetic patients who went on to develop obstructive coronary disease (OCAD) may serve as biomarkers of severe heart blockage.
October 29, 2020
Donald Lynch, MD, a University of Cincinnati cardiologist, is partnering with researchers in St. Louis and rural Georgia to develop a smartphone app that will deliver COVID-19 information and education that is targeted toward Black communities.
February 15, 2022
The University of Cincinnati is joining a nationwide study to evaluate repurposed medications in the search for effective, safe treatments for mild-to-moderate COVID-19. Repurposed medications are those already approved by the U.S. Food and Drug Administration for other indications. ACTIV-6, “The Randomized Trial to Evaluate Efficacy of Repurposed Medications,” is a nationwide double-blind study expected to enroll nearly 15,000 participants from across the United States through its website.
February 29, 2024
Rwanda faces a critical shortage of medical specialists. The University of Cincinnati's UC Rwanda Initiative has partnered with the country's ministry of health, the national University of Rwanda and the country’s teaching hospitals to develop cardiology fellowships through virtual courses and bidirectional exchange. The first two fellows visited UC for eight weeks.